Some employers and university courses require a TB blood test or Mantoux test result as part of their entry requirements.
We offer the QuantiFERON-TB Gold (QFT). This is a simple blood test that aids in the detection of Mycobacterium tuberculosis, the bacteria which causes tuberculosis (TB). QFT is an interferon-gamma (IFN-γ) release assay, commonly known as an IGRA, and is a modern alternative to the tuberculin skin test (TST, PPD or Mantoux).
Unlike the TST, QFT is a controlled laboratory test that requires only one patient visit and is unaffected by previous Bacille Calmette-Guerin (BCG) vaccination.
QFT is highly specific and sensitive: a positive result is strongly predictive of true infection with M. tuberculosis. However, like the TST and other IGRAs, QFT cannot distinguish between active tuberculosis disease and latent tuberculosis infection, and is intended for use with risk assessment, radiography, and other medical and diagnostic evaluations. Like any diagnostic aid, QFT cannot replace clinical judgment.
The US Centers for Disease Control (CDC) Guidelines recommend the use of IGRAs in all situations in which the TST was historically used, with IGRAs being the preferred test for persons who have been BCG vaccinated or are unlikely to return for TST reading.
The Quantiferon blood test is taken during a blood test appointment. The cost of the test is £101 in addition to the appointment cost and the turnaround time is 3 business days.